Breathing New Life into COPD with Ensifentrine

Please join us for the next Pharmacy Resident Seminar presentation of the Fall semester on Thursday, September 12, 2024.

Speaker: Hannah Ayers, PharmD

Speaker Title: PGY2 Ambulatory Care Pharmacy Resident

Type of Activity: Knowledge-based                  Target Audience: Pharmacists

Time: Thursday, September 12, 2024,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:

• Meeting link: https://go.uic.edu/ResidentSeminarZoomLink
  Meeting ID: 882 7458 6898
  Passcode: ufR6QATm

OR

• Join by phone: 1-312-626-6799 (Chicago)
  Meeting ID: 882 7458 6898
  Passcode: 85658814

Series Learning Objectives:  

• Describe a current controversy in pharmacy clinical practice.
• Discuss the current literature around the controversy, strengths, and weaknesses of methodology.

Seminar Learning Objectives:  

• Describe current challenges in the management of chronic obstructive pulmonary disease (COPD).
• Summarize efficacy and safety evidence of phosphodiesterase inhibitors in COPD management.
• Identify ensifentrine’s place in therapy for COPD management.

Disclosure:  Dr. Lori Wilken, a reviewer who contributed to this activity, is a consultant for OptumRx and a former consultant for Astra Zeneca. All of the relevant financial relationships listed for Dr. Lori Wilken have been mitigated through peer review. The speaker, planning committee members, and other reviewers who contributed to this activity have no relevant conflicts of interest to disclose.